News | November 10, 2021
Pulmatrix resolves dispute with Cipla
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
The drug helps in managing cholesterol
It is the world’s first DNA-based Covid vaccine
The transplant procedure was completed in under two hours
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
Subscribe To Our Newsletter & Stay Updated
